Previous issues
-
Previous issues
Volume 29(2) Apr 2023
Print ISSN: 2287-2728
Online ISSN: 2287-285X
- Reviews Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
- Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
- Clin Mol Hepatol. 2023;29(2):197-205.
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
- Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
- Clin Mol Hepatol. 2023;29(2):206-216.
- Clinical practice guidelines and real-life practice on hepatocellular carcinoma: A the Hong Kong perspective
- Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2023;29(2):217-229.
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
- Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu
- Clin Mol Hepatol. 2023;29(2):230-241.
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
- Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi
- Clin Mol Hepatol. 2023;29(2):242-251.
- Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
- Yuri Cho, Bo Hyun Kim, Joong-Won Park
- Clin Mol Hepatol. 2023;29(2):252-262.
- The role of different viral biomarkers on the management of chronic hepatitis B
- Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2023;29(2):263-276.
- Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
- Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan
- Clin Mol Hepatol. 2023;29(2):277-292.
- Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
- Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, Beatriz San-Miguel, María J. Tuñón, Javier González-Gallego, José L. Mauriz
- Clin Mol Hepatol. 2023;29(2):293-319.
- Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
- Shang-Chin Huang, Chun-Jen Liu
- Clin Mol Hepatol. 2023;29(2):320-331.
- Editorials What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
- Min Kyung Park, Yoon Jun Kim
- Clin Mol Hepatol. 2023;29(2):332-334.
- Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
- Do Young Kim
- Clin Mol Hepatol. 2023;29(2):335-338.
- The clinical management of hepatocellular carcinoma in China: Progress and challenges
- Shan Shan, Jidong Jia
- Clin Mol Hepatol. 2023;29(2):339-341.
- Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences
- Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen
- Clin Mol Hepatol. 2023;29(2):342-344.
- The prime time for management of hepatocellular carcinoma in Hong Kong
- Landon L. Chan, Stephen L. Chan
- Clin Mol Hepatol. 2023;29(2):345-348.
- Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
- Shen-Yung Wang
- Clin Mol Hepatol. 2023;29(2):349-351.
- Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan
- San-Chi Chen
- Clin Mol Hepatol. 2023;29(2):352-354.
- The latest global burden of liver cancer: A past and present threat
- Joo Hyun Oh, Dae Won Jun
- Clin Mol Hepatol. 2023;29(2):355-357.
- The current trends in the health burden of primary liver cancer across the globe
- Peter Konyn, Aijaz Ahmed, Donghee Kim
- Clin Mol Hepatol. 2023;29(2):358-362.
- The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
- Moon Haeng Hur, Jeong-Hoon Lee
- Clin Mol Hepatol. 2023;29(2):363-366.
- Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
- Joo Hyun Oh, Dong Hyun Sinn
- Clin Mol Hepatol. 2023;29(2):367-370.
- Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
- Eileen Laurel Yoon, Dae Won Jun
- Clin Mol Hepatol. 2023;29(2):371-373.
- The growing burden of non-alcoholic fatty liver disease on mortality
- Ju-Yeon Cho, Won Sohn
- Clin Mol Hepatol. 2023;29(2):374-376.
- Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
- Ho Soo Chun, Minjong Lee
- Clin Mol Hepatol. 2023;29(2):377-380.
- Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
- Heejoon Jang, Won Kim
- Clin Mol Hepatol. 2023;29(2):381-383.
- Implications of comorbidities in nonalcoholic fatty liver disease
- Sherlot Juan Song, Vincent Wai-Sun Wong
- Clin Mol Hepatol. 2023;29(2):384-389.
- Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
- Philipp Kasper, Münevver Demir, Hans-Michael Steffen
- Clin Mol Hepatol. 2023;29(2):390-393.
- Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
- Lynna Alnimer, Mazen Noureddin
- Clin Mol Hepatol. 2023;29(2):394-397.
- Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
- Maamon Basheer, Mohamed Naffaa, Nimer Assy
- Clin Mol Hepatol. 2023;29(2):398-400.
- Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
- Kee-Huat Chuah, Wah-Kheong Chan
- Clin Mol Hepatol. 2023;29(2):401-403.
- Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
- Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang
- Clin Mol Hepatol. 2023;29(2):404-407.
- The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
- Ji-Won Park, Ki Tae Suk
- Clin Mol Hepatol. 2023;29(2):408-410.
- How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
- Byeong Geun Song, Dong Hyun Sinn
- Clin Mol Hepatol. 2023;29(2):411-413.
- The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
- Young-Joo Jin
- Clin Mol Hepatol. 2023;29(2):414-416.
- Original Articles Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
- Kathryn Jane Waller, Hajar Saihi, Wenhao Li, James Hallimond Brindley, Anja De Jong, Wing-kin Syn, Conrad Bessant, William Alazawi
- Clin Mol Hepatol. 2023;29(2):417-432.
- Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
- Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
- Clin Mol Hepatol. 2023;29(2):433-452.
- Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
- Yi-Te Lee, Mohammad A. Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
- Clin Mol Hepatol. 2023;29(2):453-464.
- Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions
- Jing Yang, Xujiao Tang, Zhu Liang, Mingzhu Chen, Lixin Sun
- Clin Mol Hepatol. 2023;29(2):465-481.
- Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
- Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
- Clin Mol Hepatol. 2023;29(2):482-495.
- Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
- Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Suk Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong
- Clin Mol Hepatol. 2023;29(2):496-509.
- Letter to the Editor Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”
- Chia-Ming Chu, Yun-Fan Liaw
- Clin Mol Hepatol. 2023;29(2):510-512.
- Correspondence Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
- Jeong-Ju Yoo, Sang Gyune Kim
- Clin Mol Hepatol. 2023;29(2):513-515.
- Snapshot Systemic therapy in advanced hepatocellular carcinoma
- Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang
- Clin Mol Hepatol. 2023;29(2):516-519.